MYBPC3 and cardiac hypertrophy: Mearini et al.159 have shown that a single administration of AAV9-MYBPC3 in neonatal homozygous MYBPC3-targeted knock-in mice can prevent the development of cardiac hypertrophy and lead to a dose-dependent increase in MYBPC3 protein expression.